In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (-)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase

被引:10
|
作者
Celik, Haydar [1 ]
Kosar, Muberra [2 ]
Arinc, Emel [3 ,4 ]
机构
[1] Erciyes Univ, Fac Pharm, Dept Pharmaceut Basic Sci, TR-38039 Kayseri, Turkey
[2] Erciyes Univ, Fac Pharm, Dept Pharmacognosy, TR-38039 Kayseri, Turkey
[3] Middle E Tech Univ, Biochem Grad Programme, TR-06800 Ankara, Turkey
[4] Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey
关键词
Cytochrome b5 reduction; Flavonoids; Myricetin; IC50; Inhibition kinetics; Structure-activity relationship; AMINO-ACID-SEQUENCE; NADH-CYTOCHROME-B5; REDUCTASE; DIETARY FLAVONOIDS; FORMS; B(5); PURIFICATION; INHIBITION; TERMINUS; PROTEINS; OXIDASE;
D O I
10.1016/j.tox.2013.03.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The microsomal NADH-dependent electron transport system consisting of cytochrome b5 reductase and cytochrome b5 participates in a number of physiologically important processes including lipid metabolism as well as is involved in the metabolism of various drug and xenobiotics. In the present study, we assessed the inhibitory effects of eight dietary flavonoids representing five distinct chemical classes on cytochrome b5 reduction by purified cytochrome b5 reductase. From the flavonoids tested, myricetin was the most potent in inhibiting cytochrome b5 reduction with an IC50 value of 0.35 mu M. Myricetin inhibited b5 reductase noncompetitively with a K-i of 0.21 mu M with respect to cofactor NADH, and exhibited a non-linear relationship indicating non-Michaelis-Menten kinetic binding with respect to cytochrome b5. In contrast to the potent inhibitory activity of myricetin, (+)-taxifolin was found to be a weak inhibitor (IC50 =.9.8 mu M). The remaining flavonoids were inactive within the concentration range tested (1-50 mu M). Analysis of structure-activity data suggested that simultaneous presence of three OH groups in ring B is a primary structural determinant for a potent enzyme inhibition. Our results suggest that inhibition of the activity of this system by myricetin or myricetin containing diets may influence the metabolism of therapeutic drugs as well as detoxification of xenobiotics. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 50 条
  • [11] Role of carboxyl residues surrounding heme of human cytochrome b5 in the electrostatic interaction with NADH-cytochrome b5 reductase
    Kawano, M
    Shirabe, K
    Nagai, T
    Takeshita, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (03) : 666 - 669
  • [12] CLINICAL AND BIOLOGICAL HETEROGENEITY OF NADH-CYTOCHROME B5 REDUCTASE DEFICIENCY
    KAPLAN, JC
    LEROUX, A
    BEAUVAIS, P
    HUMAN HEREDITY, 1977, 27 (03) : 188 - 188
  • [13] ENZYMATIC SOLUBILIZATION OF MICROSOMAL NADH-CYTOCHROME B5 REDUCTASE BY LYSOSOMES
    TAKESUE, S
    OMURA, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1968, 30 (06) : 723 - &
  • [14] NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans
    Trepanier, LA
    Kurian, JR
    Miller, JL
    Bajad, S
    Chin, NA
    DRUG METABOLISM REVIEWS, 2003, 35 : 114 - 114
  • [15] NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans
    Kurian, JR
    Bajad, SU
    Miller, JL
    Chin, NA
    Trepanier, LA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (03): : 1171 - 1178
  • [16] KINETIC-PROPERTIES OF PURIFIED SHEEP LUNG MICROSOMAL NADH-CYTOCHROME B5 REDUCTASE
    GURAY, T
    ARINC, E
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1991, 23 (11): : 1315 - 1320
  • [17] Genetic variability of cytochrome b5 and NADH cytochrome b5 reductase: SNP discovery and characterization
    Sacco, James Carmel
    Trepanier, Lauren A.
    FASEB JOURNAL, 2009, 23
  • [18] Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5
    Kurian, Joseph R.
    Chin, Nathaniel A.
    Longlais, Brett J.
    Hayes, Kristie L.
    Trepanier, Lauren A.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (10) : 1366 - 1373
  • [19] Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase
    Saulter, JY
    Kurian, JR
    Trepanier, LA
    Tidwell, RR
    Bridges, AS
    Boykin, DW
    Stephens, CE
    Anbazhagan, M
    Hall, JE
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (12) : 1886 - 1893
  • [20] Simulation study of interactions and reactivities between NADH cytochrome b5 reductase and cytochrome b5
    Asada, Toshio
    Nagase, Shigeru
    Nishimoto, Kichisuke
    Koseki, Shiro
    JOURNAL OF MOLECULAR LIQUIDS, 2009, 147 (1-2) : 139 - 144